Hormone Therapy

Hormone Therapy - most related articles:

- Cancer risk found for long-term hormone therapy - 5.8
- Hormone therapy at menopause may lead to breast cancer - 5.2
- Combined hormone therapy makes breast cancer detection difficult - 4.6
- Hormone therapy may increase ovarian cancer risk - 4.5
- Hormone therapy HRT may shrink brain - 4.2
- Low income breast cancer patients skipping hormonal therapy - 4.2
- Breast cancer relapse risk low after 5 years - 4.2
- Less hormone therapy use in women reduced breast cancer rate - 4.1
- Hormone therapy reduces woman's risk of colorectal cancer by 40% - 4.1
- 49% breast cancer patients adhere to hormonal therapy regimen - 3.9

Hormone Therapy articles

Moderate weight loss reduces breast cancer risk
Even a moderate amount of weight loss can significantly reduce levels of circulating estrogens that are associated with an increased risk of breast cancer, revealed by researchers at Fred Hutchinson Cancer Research Center.

Increasing height and body mass index linked to ovarian cancer risk
Increasing height and, among women who have never taken menopausal hormone therapy, increased body mass index are risk factors for developing ovarian cancer in women, revealed by researchers.

Long term hormone therapy linked to higher breast cancer risk
Long-term use of estrogen plus progesterone and estrogen-only hormone therapy is linked with a higher risk for developing breast cancer. Researchers found this breast cancer risk was 88 percent higher.

Therapy reduces early menopause for women with breast cancer
Temporarily suppressing ovarian function with use of the hormone analogue triptorelin reduced the occurrence of early menopause induced by chemotherapy among women with breast cancer, according to a study in the July_20 issue of JAMA.

Obese men face higher risk of prostate cancer progression
Even when treated with hormone therapy to suppress tumor growth, obese men face an elevated risk of their prostate cancer worsening, researchers at Duke University Medical Center have found.

Hormone therapy at menopause may lead to breast cancer
Hormone therapy around menopause is linked to breast cancer risk, revealed by researchers in a study published in The Journal of the National Cancer Institute.

Age plays too big a role in prostate cancer treatment decisions
Older men with high-risk prostate cancer frequently are offered fewer – and less effective – choices of treatment than younger men, potentially resulting in earlier deaths, according to a new UCSF study.

Potential target identified for therapy for prostate cancer
A monoclonal antibody targeting a well known cell surface protein inhibited prostate cancer growth and metastasis in an aggressive form of the disease that did not respond to hormone therapy.

Cancer risk found for long-term hormone therapy
Using postmenopausal hormone therapy for more than 15 years increases a woman's risk of developing breast cancer, particularly among leaner women according to research at the Keck School of Medicine of the University of Southern California (USC).

49% breast cancer patients adhere to hormonal therapy regimen
A new study of nearly 8,800 women with early-stage breast cancer found that fewer than half – approximately 49 percent – completed their full regimen of hormone therapy according to the prescribed schedule.

Less hormone therapy use in women reduced breast cancer rate
The decreased use of postmenopausal hormone therapy has played a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer, revealed by researchers.

Hormone therapy may increase ovarian cancer risk
Compared with women who have never taken hormone therapy, those who currently take it or who have taken it in the past are at increased risk of ovarian cancer.

Success with ipilimumab in prostate cancer patients
Two Mayo Clinic patients whose prostate cancer had been considered inoperable are now cancer free thanks in part to an experimental drug therapy that was used in combination with standardized hormone treatment and radiation therapy.

HRT-breast cancer risk stays same regardless of family history
The risk of developing breast cancer due to taking hormone replacement therapy appears to be the same for women with a family history of the disease and without a family history, a University of Rochester Medical Center study concluded.

Hormone therapy reduces woman's risk of colorectal cancer by 40%
In a large study, a national team of researchers led by Mayo Clinic scientists observed that self-reported use of hormone therapy was associated with a significantly lower colorectal cancer risk. However, the mechanisms for the apparent protective association are still unclear.

Hormone therapy HRT may shrink brain
Two new studies show that hormone therapy for women is linked to brain shrinkage, but not to the small brain lesions that are the first sign of cerebrovascular disease.

Obesity linked to ovarian cancer risk
A new epidemiological study has found that among women who have never used menopausal hormone therapy, obese women are at an increased risk of developing ovarian cancer compared with women of normal weight.

No increased risk of heart attacks in users of HRT
It's not what you take but the way that you take it that can produce different results in women who take hormone replacement therapy (HRT), according to new research on the association between HRT and heart attacks, published online in Europe's leading cardiology journal, the European Heart Journal.

Lumpectomy, radiation improve life in breast cancer patients
Women with breast cancer who are treated with lumpectomy and radiation report a high level of overall quality of life several years after treatment that is comparable to a general sampling of the adult women U.S. population according to a survey conducted by physicians at Fox Chase Cancer Center.

Breast cancer relapse risk low after 5 years
Breast cancer survivors continue to have a substantial risk of disease recurrence after five years of systemic therapy, according to a study published in the August 12 online issue of the Journal of the National Cancer Institute.

Oral HRT doubles risk of blood clots
Hormone replacement therapy (HRT) given in skin patches may cause fewer blood clots than HRT given orally, revealed by researchers in British Medical Journal, UK. Women who take the oral form of HRT more than double their risk of developing a blood clot.

Hormone replacement therapy increases breast cancer recurrence
A new study HABITS revealed that breast cancer survivors who took hormone replacement therapy (HRT) for peri- and postmenopausal symptoms increases disease recurrence than those who did not take HRT.

Aspirin may reduce breast cancer by 20%
Anti-inflammatory drugs like aspirin may reduce breast cancer by up to 20 per cent, according to an extensive review carried out by experts at London's Guy's Hospital and published in the March issue of IJCP, the International Journal of Clinical Practice.

Combined hormone therapy makes breast cancer detection difficult
Combined hormone therapy appears to increase the risk that women will have abnormal mammograms and breast biopsies, and it may decrease the effectiveness of both methods for detecting breast cancer, according to a report in the Feb. 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Oral contraceptive pills can protect against ovarian cancer
Use of oral contraceptives during a woman's life-time gives substantial long-term protection against ovarian cancer and the longer they are used, the greater the reduction in risk. These are the conclusions of authors of an Article in this week's edition of The Lancet - a medical journal in the United Kingdom.

Combined hormone therapy increases lobular breast cancer risk
Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers.

26 Hormone Therapy articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
3.06